Pouya Tayebi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pouya Tayebi has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
Ali Bijani
Babol University of Medical Sciences, Mazandaran, Iran
7 shared publications- Naghmeh Ziaie
Clinical Research Development Unit, Rohani Hospital Babol University of Medical Sciences Babol Iran
5 shared publications - Ali Bijani
Social Determinant of Health Research Center, Babol University of Medical Sciences, Babol, Iran
4 shared publications Fatemeh Mahmoudlou
Student Research Committee, Babol University of Medical Sciences, Babol, Iran
4 shared publications- Mohammad Barary
Student Research Committee, Department of Pharmacology School of Medicine, Shahid Beheshti University of Medical Sciences Tehran Iran
4 shared publications - Soheil Ebrahimpour
Infectious Diseases and Tropical Medicine Research Center Health Research Institute, Babol University of Medical Sciences Babol Iran
4 shared publications
Latest Publications
- 15 October 2026
- Published by Georg Thieme Verlag KG in International Journal of Angiology
Arterial Stiffness Changes Following Chemotherapy in Patients with Breast Cancer: A Prospective Observational Study
Systemic chemotherapy is an important component of breast cancer treatment but may be associated with cardiovascular toxicity. Arterial stiffness, assessed by central pulse wave velocity (cPWV), is a marker of vascular aging and cardiovascular risk. This study evaluated changes in cPWV following systemic chemotherapy in women with breast cancer. This prospective observational cohort study included 111 women with histologically confirmed breast cancer who completed planned systemic chemotherapy. cPWV was measured before chemotherapy and after treatment completion. Demographic, clinical, tumor-related, and treatment-related variables were collected. The primary outcome was the change in cPWV after chemotherapy. Paired tests and multivariable linear regression were used for analysis. Mean cPWV increased significantly from 6.55 ± 0.94 m/s at baseline to 7.58 ± 1.52 m/s after chemotherapy (p < 0.001). The mean ΔcPWV was 1.02 ± 0.82 m/s, and 84.7% of patients showed increased cPWV. No significant differences in ΔcPWV were observed among chemotherapy regimens or drug-class exposures. In obese patients, cPWV increased numerically but not significantly. In multivariable analysis, age, baseline cPWV, and hypertension were independently associated with ΔcPWV. Systemic chemotherapy was associated with a significant increase in arterial stiffness in women with breast cancer, as demonstrated by changes in cPWV after treatment. These findings suggest that chemotherapy may be accompanied by measurable vascular alterations in addition to previously recognized cardiac effects.
- 15 October 2026
- Published by Georg Thieme Verlag KG in International Journal of Angiology
Arterial Stiffness Changes Following Chemotherapy in Patients with Breast Cancer: A Prospective Observational Study
Systemic chemotherapy is an important component of breast cancer treatment but may be associated with cardiovascular toxicity. Arterial stiffness, assessed by central pulse wave velocity (cPWV), is a marker of vascular aging and cardiovascular risk. This study evaluated changes in cPWV following systemic chemotherapy in women with breast cancer. This prospective observational cohort study included 111 women with histologically confirmed breast cancer who completed planned systemic chemotherapy. cPWV was measured before chemotherapy and after treatment completion. Demographic, clinical, tumor-related, and treatment-related variables were collected. The primary outcome was the change in cPWV after chemotherapy. Paired tests and multivariable linear regression were used for analysis. Mean cPWV increased significantly from 6.55 ± 0.94 m/s at baseline to 7.58 ± 1.52 m/s after chemotherapy (p < 0.001). The mean ΔcPWV was 1.02 ± 0.82 m/s, and 84.7% of patients showed increased cPWV. No significant differences in ΔcPWV were observed among chemotherapy regimens or drug-class exposures. In obese patients, cPWV increased numerically but not significantly. In multivariable analysis, age, baseline cPWV, and hypertension were independently associated with ΔcPWV. Systemic chemotherapy was associated with a significant increase in arterial stiffness in women with breast cancer, as demonstrated by changes in cPWV after treatment. These findings suggest that chemotherapy may be accompanied by measurable vascular alterations in addition to previously recognized cardiac effects.
- 1 September 2026
- Published by Georg Thieme Verlag KG in International Journal of Angiology
Arterial Stiffness and Peripheral Arterial Status in Patients with Diabetic Foot Ulcers: A Cross-sectional Comparative Study
Diabetic foot ulcer (DFU) is associated with substantial vascular morbidity, but the relationship between DFU, central arterial stiffness, and peripheral arterial impairment remains incompletely defined. This study compared central pulse wave velocity (cPWV) and ankle–brachial index (ABI) between patients with DFU and non-diabetic clinic controls. This cross-sectional comparative study included 72 participants: 36 patients with type 2 diabetes mellitus and Wagner grade 1 or 2 DFU and 36 non-diabetic clinic controls. Central PWV and ABI were measured automatically using the AngE Pro 4 system. Between-group comparisons, categorical analyses using cPWV > 8 m/s and ABI < 0.90, and Pearson's correlation analyses were performed using SPSS version 22. Mean cPWV did not differ significantly between the DFU and control groups (7.758 ± 2.016 vs. 7.456 ± 2.816 m/s; p = 0.602). Mean ABI did not differ significantly between groups (1.056 ± 0.334 vs. 1.109 ± 0.290; p = 0.475). Elevated cPWV (> 8 m/s) was observed in 30.6% of patients with DFU and 25.0% of controls (p = 0.601). ABI < 0.90 was more frequent in the DFU group (36.1% vs. 19.4%; OR = 2.342, 95% CI: 0.804–6.823), although the difference was not statistically significant (p = 0.117). Central PWV showed a weak positive correlation with systolic blood pressure (r = 0.247, p = 0.037). Patients with Wagner grade 1 or 2 DFU did not demonstrate significantly greater central arterial stiffness or lower mean ABI than non-diabetic clinic controls. However, abnormal ABI was numerically more frequent in the DFU group. Larger prospective studies are needed to clarify the vascular significance of cPWV and ABI in diabetic foot disease.
- 1 September 2026
- Published by Georg Thieme Verlag KG in International Journal of Angiology
Arterial Stiffness and Peripheral Arterial Status in Patients with Diabetic Foot Ulcers: A Cross-sectional Comparative Study
Diabetic foot ulcer (DFU) is associated with substantial vascular morbidity, but the relationship between DFU, central arterial stiffness, and peripheral arterial impairment remains incompletely defined. This study compared central pulse wave velocity (cPWV) and ankle–brachial index (ABI) between patients with DFU and non-diabetic clinic controls. This cross-sectional comparative study included 72 participants: 36 patients with type 2 diabetes mellitus and Wagner grade 1 or 2 DFU and 36 non-diabetic clinic controls. Central PWV and ABI were measured automatically using the AngE Pro 4 system. Between-group comparisons, categorical analyses using cPWV > 8 m/s and ABI < 0.90, and Pearson's correlation analyses were performed using SPSS version 22. Mean cPWV did not differ significantly between the DFU and control groups (7.758 ± 2.016 vs. 7.456 ± 2.816 m/s; p = 0.602). Mean ABI did not differ significantly between groups (1.056 ± 0.334 vs. 1.109 ± 0.290; p = 0.475). Elevated cPWV (> 8 m/s) was observed in 30.6% of patients with DFU and 25.0% of controls (p = 0.601). ABI < 0.90 was more frequent in the DFU group (36.1% vs. 19.4%; OR = 2.342, 95% CI: 0.804–6.823), although the difference was not statistically significant (p = 0.117). Central PWV showed a weak positive correlation with systolic blood pressure (r = 0.247, p = 0.037). Patients with Wagner grade 1 or 2 DFU did not demonstrate significantly greater central arterial stiffness or lower mean ABI than non-diabetic clinic controls. However, abnormal ABI was numerically more frequent in the DFU group. Larger prospective studies are needed to clarify the vascular significance of cPWV and ABI in diabetic foot disease.
- Open Access
- 1 September 2026
- Published by Springer Nature in Artery Research
- Vol. 32 (1) , 27
Effect of Melatonin and Melatonin Receptor agonist Supplementation on Vascular Stiffness: A Systematic Review and Meta-analysis
Background: Arterial stiffness is a critical precursor to clinical cardiovascular disease. This systematic review and meta-analysis aimed to evaluate the impact of melatonin and its receptor agonists on markers of arterial stiffness and hemodynamic parameters in adults. Methods: A comprehensive search was performed across PubMed, Scopus, EMBASE, Web of Science, and Cochrane CENTRAL from inception to January 31, 2026. Clinical trials investigating melatonin or its analogues in adult populations were considered eligible regardless of study design. Although both randomized and non-randomized trials were sought, all eligible studies identified through the systematic search were randomized controlled trials (RCTs). The primary outcome was pulse wave velocity (PWV). Secondary outcomes included the augmentation index (AIx) and blood pressure parameters. STATA (version 18.0) was utilized to conduct the meta-analysis via a random effects model. The risk of bias was assessed using the Cochrane Risk of Bias tool (RoB 2), and the certainty of evidence was assessed via the GRADE framework. Results: Five RCTs (319 participants) were included in the meta-analysis. Melatonin supplementation was associated with a borderline reduction in the PWV (SMD = -0.22; 95% CI: -0.44, 0.00; p = 0.05; I 2 = 0%); however, the magnitude of the effect corresponds to an estimated change below the minimal clinically important difference. No significant effect was observed for the AIx (SMD = -0.07; 95% CI: -0.30, 0.15; p = 0.51). Melatonin significantly reduced blood pressure parameters, including central systolic blood pressure (SBP) (MD= -6.14 mmHg; 95% CI: -8.94, -3.34; p < 0.001), peripheral SBP (MD = -4.67 mmHg; 95% CI: -8.05, -1.29; p = 0.01), and peripheral DBP (MD = -3.45 mmHg; 95% CI: -6.68, -0.22; p = 0.04). No significant changes were observed for central DBP (MD = 0.47 mmHg; 95% CI: -4.57, 5.50; p = 0.86). Conclusion: Current evidence does not support a clinically meaningful effect of melatonin supplementation on arterial stiffness parameters, including PWV and AIx. However, given the very low certainty of the available evidence, definitive conclusions cannot be drawn, and further high-quality randomized controlled trials are warranted . Systematic Review Registration: PROSPERO (CRD420261336398)
- 1 September 2026
- Published by Springer Nature in Artery Research
- Vol. 32 (1) , 27
Open AccessEffect of Melatonin and Melatonin Receptor agonist Supplementation on Vascular Stiffness: A Systematic Review and Meta-analysis
Background: Arterial stiffness is a critical precursor to clinical cardiovascular disease. This systematic review and meta-analysis aimed to evaluate the impact of melatonin and its receptor agonists on markers of arterial stiffness and hemodynamic parameters in adults. Methods: A comprehensive search was performed across PubMed, Scopus, EMBASE, Web of Science, and Cochrane CENTRAL from inception to January 31, 2026. Clinical trials investigating melatonin or its analogues in adult populations were considered eligible regardless of study design. Although both randomized and non-randomized trials were sought, all eligible studies identified through the systematic search were randomized controlled trials (RCTs). The primary outcome was pulse wave velocity (PWV). Secondary outcomes included the augmentation index (AIx) and blood pressure parameters. STATA (version 18.0) was utilized to conduct the meta-analysis via a random effects model. The risk of bias was assessed using the Cochrane Risk of Bias tool (RoB 2), and the certainty of evidence was assessed via the GRADE framework. Results: Five RCTs (319 participants) were included in the meta-analysis. Melatonin supplementation was associated with a borderline reduction in the PWV (SMD = -0.22; 95% CI: -0.44, 0.00; p = 0.05; I 2 = 0%); however, the magnitude of the effect corresponds to an estimated change below the minimal clinically important difference. No significant effect was observed for the AIx (SMD = -0.07; 95% CI: -0.30, 0.15; p = 0.51). Melatonin significantly reduced blood pressure parameters, including central systolic blood pressure (SBP) (MD= -6.14 mmHg; 95% CI: -8.94, -3.34; p < 0.001), peripheral SBP (MD = -4.67 mmHg; 95% CI: -8.05, -1.29; p = 0.01), and peripheral DBP (MD = -3.45 mmHg; 95% CI: -6.68, -0.22; p = 0.04). No significant changes were observed for central DBP (MD = 0.47 mmHg; 95% CI: -4.57, 5.50; p = 0.86). Conclusion: Current evidence does not support a clinically meaningful effect of melatonin supplementation on arterial stiffness parameters, including PWV and AIx. However, given the very low certainty of the available evidence, definitive conclusions cannot be drawn, and further high-quality randomized controlled trials are warranted . Systematic Review Registration: PROSPERO (CRD420261336398)
- Open Access
- 6 February 2026
- Published by Georg Thieme Verlag KG in International Journal of Angiology
The Role of Arterial Stiffness in the Prognosis, Assessment, and Treatment of Patients with Peripheral Artery Disease: A Comprehensive Review
Peripheral artery disease (PAD) is a prevalent and disabling vascular condition characterized by progressive atherosclerotic narrowing and stiffening of peripheral arteries. Arterial stiffness, most accurately measured by pulse wave velocity (PWV), has gained prominence as a critical biomarker in the assessment and management of PAD. Unlike traditional diagnostic tools that focus primarily on anatomical lesions, PWV offers dynamic insights into vascular function, elasticity, and systemic cardiovascular risk. Elevated PWV has been consistently associated with adverse outcomes in PAD patients, including critical limb ischemia, restenosis following angioplasty, amputation, and cardiovascular mortality. It not only reflects disease severity but also facilitates early risk stratification, informs treatment selection, and enables monitoring of therapeutic efficacy. Studies have shown that reductions in arterial stiffness following angioplasty, pharmacological therapy, or lifestyle interventions correlate with improved limb perfusion and long-term clinical outcomes. Moreover, in elderly PAD patients, arterial stiffness often coexists with frailty—another key predictor of poor prognosis. Emerging evidence suggests that both conditions may share pathophysiological pathways related to vascular aging and sarcopenia. The integration of PWV into routine PAD evaluation may thus offer a more holistic understanding of patient risk and resilience. Given its diagnostic, prognostic, and therapeutic utility, arterial stiffness—particularly as assessed by PWV—should be considered an essential parameter in PAD management. Incorporating this measurement into clinical practice holds significant potential to improve individualized care, reduce complications, and enhance overall patient outcomes.
- 6 February 2026
- Published by Georg Thieme Verlag KG in International Journal of Angiology
Open AccessThe Role of Arterial Stiffness in the Prognosis, Assessment, and Treatment of Patients with Peripheral Artery Disease: A Comprehensive Review
Peripheral artery disease (PAD) is a prevalent and disabling vascular condition characterized by progressive atherosclerotic narrowing and stiffening of peripheral arteries. Arterial stiffness, most accurately measured by pulse wave velocity (PWV), has gained prominence as a critical biomarker in the assessment and management of PAD. Unlike traditional diagnostic tools that focus primarily on anatomical lesions, PWV offers dynamic insights into vascular function, elasticity, and systemic cardiovascular risk. Elevated PWV has been consistently associated with adverse outcomes in PAD patients, including critical limb ischemia, restenosis following angioplasty, amputation, and cardiovascular mortality. It not only reflects disease severity but also facilitates early risk stratification, informs treatment selection, and enables monitoring of therapeutic efficacy. Studies have shown that reductions in arterial stiffness following angioplasty, pharmacological therapy, or lifestyle interventions correlate with improved limb perfusion and long-term clinical outcomes. Moreover, in elderly PAD patients, arterial stiffness often coexists with frailty—another key predictor of poor prognosis. Emerging evidence suggests that both conditions may share pathophysiological pathways related to vascular aging and sarcopenia. The integration of PWV into routine PAD evaluation may thus offer a more holistic understanding of patient risk and resilience. Given its diagnostic, prognostic, and therapeutic utility, arterial stiffness—particularly as assessed by PWV—should be considered an essential parameter in PAD management. Incorporating this measurement into clinical practice holds significant potential to improve individualized care, reduce complications, and enhance overall patient outcomes.
- 9 December 2025
- Published by Wiley in Sonography
- Vol. 13 (1)
Assessing the Severity of Peripheral Arterial Disease: Doppler Ultrasound Compared to Digital Subtraction Angiography in Distal Limb Arteries
Introduction: Accurate and timely diagnosis of peripheral arterial disease (PAD) is essential to prevent progression and guide effective treatment. This study aims to compare the diagnostic accuracy and limitations of Doppler ultrasonography (DUS) and digital subtraction angiography (DSA) in evaluating the severity and anatomical distribution of PAD, particularly in infra‐popliteal arteries, to improve diagnostic decision‐making in vascular care. Methods: This cross‐sectional study involved 40 PAD patients scheduled for lower limb revascularization. All participants underwent both DUS and DSA. DUS was performed by experienced sonographers using a standardized protocol to assess both supra‐ and infra‐popliteal arteries, while DSA was conducted during the procedure with contrast‐enhanced x‐ray imaging. Diagnostic performance and concordance between DUS and DSA were analyzed using chi‐square tests, Kappa coefficient, and correlation (Pearson and Spearman). Results: A total of 504 arterial sections were analyzed. The concordance between DUS and DSA was 63.5% for supra‐popliteal arteries and 34.9% for infra‐popliteal arteries. DUS demonstrated higher diagnostic accuracy in the supra‐popliteal regions, with a positive predictive value (PPV) of 83.2% and a negative predictive value (NPV) of 85.4%. However, in infra‐popliteal arteries, the PPV and NPV were lower (68.5% and 72.3%, respectively), indicating reduced reliability in detecting distal arterial lesions. Conclusion: DUS is a valuable non‐invasive tool for assessing PAD in supra‐popliteal arteries but has limited accuracy in infra‐popliteal evaluations. Supplementary imaging modalities such as DSA remain essential for precise diagnosis and treatment planning in distal arterial disease.
- 9 December 2025
- Published by Wiley in Sonography
- Vol. 13 (1)
Assessing the Severity of Peripheral Arterial Disease: Doppler Ultrasound Compared to Digital Subtraction Angiography in Distal Limb Arteries
Introduction: Accurate and timely diagnosis of peripheral arterial disease (PAD) is essential to prevent progression and guide effective treatment. This study aims to compare the diagnostic accuracy and limitations of Doppler ultrasonography (DUS) and digital subtraction angiography (DSA) in evaluating the severity and anatomical distribution of PAD, particularly in infra‐popliteal arteries, to improve diagnostic decision‐making in vascular care. Methods: This cross‐sectional study involved 40 PAD patients scheduled for lower limb revascularization. All participants underwent both DUS and DSA. DUS was performed by experienced sonographers using a standardized protocol to assess both supra‐ and infra‐popliteal arteries, while DSA was conducted during the procedure with contrast‐enhanced x‐ray imaging. Diagnostic performance and concordance between DUS and DSA were analyzed using chi‐square tests, Kappa coefficient, and correlation (Pearson and Spearman). Results: A total of 504 arterial sections were analyzed. The concordance between DUS and DSA was 63.5% for supra‐popliteal arteries and 34.9% for infra‐popliteal arteries. DUS demonstrated higher diagnostic accuracy in the supra‐popliteal regions, with a positive predictive value (PPV) of 83.2% and a negative predictive value (NPV) of 85.4%. However, in infra‐popliteal arteries, the PPV and NPV were lower (68.5% and 72.3%, respectively), indicating reduced reliability in detecting distal arterial lesions. Conclusion: DUS is a valuable non‐invasive tool for assessing PAD in supra‐popliteal arteries but has limited accuracy in infra‐popliteal evaluations. Supplementary imaging modalities such as DSA remain essential for precise diagnosis and treatment planning in distal arterial disease.
- Open Access
- 11 September 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (9) , e70135
Commentary on “Association of Triglyceride‐Glucose Body Mass Index With Target Organ Damage in Essential Hypertension: A Retrospective Cohort Study”
- 11 September 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (9) , e70135
Open AccessCommentary on “Association of Triglyceride‐Glucose Body Mass Index With Target Organ Damage in Essential Hypertension: A Retrospective Cohort Study”
- 1 September 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (5) , 2890-2891
Commentary on “Poor Nutritional Status Combined With Sarcopenia Were Associated With Increased Mortality and Amputation Rate in Patients With Lower Extremity Arterial Disease Following Endovascular Treatment”
- 1 September 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (5) , 2890-2891
Commentary on “Poor Nutritional Status Combined With Sarcopenia Were Associated With Increased Mortality and Amputation Rate in Patients With Lower Extremity Arterial Disease Following Endovascular Treatment”
- 17 August 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (4) , 2561-2566
Antegrade Access via Superficial Femoral Versus Common Femoral Arteries in Lower Extremity Revascularization: A Comparative Evaluation of Safety and Efficacy
Background: Effective revascularization in lower extremity endovascular interventions depends on reliable arterial access. While the common femoral artery (CFA) is traditionally preferred, anatomical challenges such as calcifications or scarring may necessitate alternative options like the superficial femoral artery (SFA). Aims: This prospective, non‐randomized study compares the safety and efficacy of antegrade access through CFA versus SFA in patients undergoing angioplasty. Methods: A total of 225 patients were enrolled between 2021 and 2022. Of these, 111 underwent CFA access and 114 underwent SFA access, using a six French sheath in all cases. Sheath placement was guided by duplex ultrasound or fluoroscopy. Use of closure devices was an exclusion criterion. Heparin was administered as either a single dose of 5000 IU or a double dose of 5000 IU at the beginning of the procedure followed by an additional 5000 IU 90 min later, considering the 90‐min half‐life of unfractionated heparin. Procedural variables and complications were analyzed, and crude odds ratios (ORs) were calculated. Results: Baseline characteristics, including age, gender, BMI, and comorbidities, were comparable between groups. Duplex‐guided sheath placement was more frequent in the SFA group (47.3% vs. 33.3%). The overall complication rate was significantly lower in the SFA group (3.5% vs. 9.9%, p = 0.033). Most complications, including hematomas and pseudoaneurysms, were observed in the CFA group. No significant predictors of complication could be identified in OR analysis (e.g., duplex guidance OR: 0.551; 95% CI: 0.226–1.348). Conclusion: Antegrade SFA access demonstrated a safety profile comparable to CFA access and may serve as a suitable alternative, especially when CFA access is technically difficult. The low complication rate and increased use of duplex guidance highlight its potential utility in endovascular procedures.
- 17 August 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (4) , 2561-2566
Antegrade Access via Superficial Femoral Versus Common Femoral Arteries in Lower Extremity Revascularization: A Comparative Evaluation of Safety and Efficacy
Background: Effective revascularization in lower extremity endovascular interventions depends on reliable arterial access. While the common femoral artery (CFA) is traditionally preferred, anatomical challenges such as calcifications or scarring may necessitate alternative options like the superficial femoral artery (SFA). Aims: This prospective, non‐randomized study compares the safety and efficacy of antegrade access through CFA versus SFA in patients undergoing angioplasty. Methods: A total of 225 patients were enrolled between 2021 and 2022. Of these, 111 underwent CFA access and 114 underwent SFA access, using a six French sheath in all cases. Sheath placement was guided by duplex ultrasound or fluoroscopy. Use of closure devices was an exclusion criterion. Heparin was administered as either a single dose of 5000 IU or a double dose of 5000 IU at the beginning of the procedure followed by an additional 5000 IU 90 min later, considering the 90‐min half‐life of unfractionated heparin. Procedural variables and complications were analyzed, and crude odds ratios (ORs) were calculated. Results: Baseline characteristics, including age, gender, BMI, and comorbidities, were comparable between groups. Duplex‐guided sheath placement was more frequent in the SFA group (47.3% vs. 33.3%). The overall complication rate was significantly lower in the SFA group (3.5% vs. 9.9%, p = 0.033). Most complications, including hematomas and pseudoaneurysms, were observed in the CFA group. No significant predictors of complication could be identified in OR analysis (e.g., duplex guidance OR: 0.551; 95% CI: 0.226–1.348). Conclusion: Antegrade SFA access demonstrated a safety profile comparable to CFA access and may serve as a suitable alternative, especially when CFA access is technically difficult. The low complication rate and increased use of duplex guidance highlight its potential utility in endovascular procedures.
- 15 July 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (8) , 2103-2104
Commentary on “Sodium‐Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation”
- 15 July 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (8) , 2103-2104
Commentary on “Sodium‐Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation”
- 9 July 2025
- Published by Wiley in Wound Repair and Regeneration
- Vol. 33 (4) , e70066
Commentary on “Polymicrobial Infection in Bone Biopsies and Relapse in Diabetic Foot Osteomyelitis: The Role of Soft Tissue Involvement”
- 9 July 2025
- Published by Wiley in Wound Repair and Regeneration
- Vol. 33 (4) , e70066
Commentary on “Polymicrobial Infection in Bone Biopsies and Relapse in Diabetic Foot Osteomyelitis: The Role of Soft Tissue Involvement”